تجاوز إلى المحتوى الرئيسي
User Image

Maha Meshal Abdullah AlRasheed MSc. PhD.

Associate Professor

Advisor of H.E. The President of Princess Noura Bint Abdulrahman University

كلية الصيدلة
Building 8, Floor 3, Office 34
المنشورات
مقال فى مجلة
1998

Donepezil: A new cholinesterase inhibitor for the treatment of Alzheimer’s disease

Abou-Auda, Maha M. Al-Rasheed and Hisham S. . 1998

In November 1996, donepezil hydrochloride (Aricept; Pfizer) was approved by the Food and Drug Administration (FDA) as a symptomatic therapy for mild and moderate Alzheimer's disease (AD). Although it was preceded to the United States market by tacrine (Congex; Parke-Davis) by more than 3 years, donepezil's ease of use and favorable safety profile, coupled with clinically meaningful efficacy, represent a major step forward in dementia treatment (1-6). Donepezil hydrochloride, a piperdine-based second-generation acteylcholinesterase inhibitor, is now being marketed for oral treatment of cognitive symptoms in patients with mild to moderate dementia due to Alzheimer's disease (7,8). It is the only drug licensed in Britain for the treatment of Alzheimer's disease, although tacrine, another acetylcholinestrease inhibitor, is available in the United States and France (9,10). Donepezil is the first drug approved by the Health Protection Branch of Health Canada for the symptomatic treatment of early to intermediate stages of AD. 

رقم المجلد
6
رقم الانشاء
1319-0164
مجلة/صحيفة
Saudi Pharmaceutical Journal
الصفحات
99-101
مزيد من المنشورات
publications

Introduction: Patients with differentiated thyroid cancer (DTC) are usually managed with total thyroidectomy and subsequent radioiodine ablation of the remnant thyroid tissue.

بواسطة Maha Mishal Alrasheed
2014
publications

In November 1996, donepezil hydrochloride (Aricept; Pfizer) was approved by the Food and Drug Administration (FDA) as a symptomatic therapy for mild and moderate Alzheimer's disease (AD).

بواسطة Maha M. Al-Rasheed and Hisham S. Abou-Auda
1998
publications

Aminoglycosides are bactericidal antibiotics used in the systemic treatment of serious Gram-negative infections. Multiple-daily dosing (MDD) has been the conventional method to administer…

بواسطة Alkharfy KM, Alrasheed M
2007